- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Oral Swab Test May Boost IVF Success and Reduce Side Effects: Study Finds - Video
Overview
New Delhi: A simple genetic test could significantly improve the success rate of in vitro fertilization (IVF) while reducing the risk of side effects from hormone therapy, according to a new study published in Frontiers in Endocrinology. Researchers from Lund University, Sweden, found that matching hormone treatment to a woman’s genetic profile led to a 38% increase in the number of babies born through IVF, offering new hope for couples facing infertility.
Current IVF treatments rely heavily on hormone therapy to stimulate egg maturation—an approach that carries risks. Up to 75% of IVF attempts fail, and around 20% of women experience side effects, some severe enough to require emergency care.
To personalise treatment and improve outcomes, the researchers analysed data from 1,466 women undergoing IVF at Skåne University Hospital in Malmö. Women with endometriosis or polycystic ovary syndrome (PCOS) were excluded. The team focused on variations in the FSH receptor (FSHR) gene, which influences how the body responds to follicle-stimulating hormone, a key player in egg maturation.
The study revealed that women with a specific FSHR gene variant responded better to biological hormone treatments, while others benefited more from synthetic alternatives. Tailoring hormone therapy to a woman’s genetic makeup resulted in significantly higher pregnancy rates.
To make this approach practical and cost-effective, the team developed a simple oral swab test that determines the most suitable hormone treatment within an hour. The result is visible to the naked eye as a pink or yellow color. The test is expected to be commercially available by early 2026.
"We see an increase in the number of pregnancies and a relative number of 38% more babies born among women who received hormone therapy that matched their gene variation compared with those who did not. This means that for every 1,000 women undergoing IVF treatment, the equivalent of four more school classes are born: 110 more babies," says Yvonne Lundberg Giwercman, professor at Lund University who led the research. She has been researching fertility in both men and women for many years.
Researchers hope the test will improve IVF outcomes, reduce healthcare costs, and spare women unnecessary physical and emotional strain.
References: https://www.lunduniversity.lu.se/article/higher-success-rate-using-simple-oral-swab-test-ivf
Speakers
Dr. Bhumika Maikhuri
BDS, MDS